Antibody

Fractional COVID Booster Doses Provide Strong, Long-Lasting Immunity

by

Fractional dosing of COVID-19 vaccines can provide durable, long-lasting immunity comparable to full-dose boosters, according to a multi-year international study led by the Murdoch Children’s Research Institute (MCRI). Findings published across Nature Communications, Frontiers in Immunology, and the Journal of Infection suggest that reducing vaccine volume could lower costs and expand access to immunization in … Read more

Targeted Therapy Doubles Survival in Rare Bile Duct Cancer

by

The U.S. Food and Drug Administration approved zenocutuzumab as a second-line therapy for NRG1-positive cholangiocarcinoma on May 8. According to results from the eNRGy phase 2 clinical trial published in the Journal of Clinical Oncology, the drug more than doubled the median progression-free survival to 9.2 months, compared to the approximately four months typically seen … Read more

Strengthening Global Biosecurity Through Targeted Vaccination

by

Vaccination strategies are shifting from purely clinical initiatives to integrated components of global biosafety, biosecurity, and One Health frameworks. According to a review published in the Journal of Biosafety and Biosecurity by Al-Eitan et al. (2024), tailoring immunization to high-risk occupational groups and zoonotic disease vectors is essential to preventing laboratory-acquired infections and cross-species pathogen … Read more

New Genetic Marker Linked to Severe IBD

by

Researchers from the Wellcome Sanger Institute and the Francis Crick Institute have identified a genetic marker, HLA-DRB1*01:03, that correlates with more severe ulcerative colitis and Crohn’s disease. Published in The Lancet Gastroenterology and Hepatology, the study suggests that genetic testing could help clinicians identify high-risk patients for earlier intervention with advanced therapies. How does the … Read more

New Fentanyl Vaccine Shows Promise in Preventing Opioid Overdose

by

Scripps Research scientists have developed a vaccine candidate designed to neutralize a broad class of fentanyl-related synthetic opioids by targeting a shared molecular fingerprint. According to research published in the Journal of Medicinal Chemistry on May 12, 2026, the vaccine may protect against various designer drugs while leaving therapeutic medical opioids like morphine unaffected. How … Read more

How Germinal Centers Consistently Produce Antibodies: New Study Findings

by

A new study published in Cell on May 2026 reveals that germinal centers function like a “molecular casino,” where the immune system uses statistical bias rather than perfect selection to produce high-affinity antibodies. By tracking thousands of B cells across 119 germinal centers in mice, researchers at The Rockefeller University discovered that these structures are … Read more

Alzheimer’s monoclonal antibodies fail to deliver meaningful results

by

The Amyloid Paradox: Clearing Plaques vs. Restoring Memory For years, the scientific community focused on the “amyloid hypothesis”—the idea that removing amyloid-beta (Aβ) plaques from the brain would stop or reverse Alzheimer’s disease. Recent data shows a complex reality: while monoclonal antibodies (mAbs) are highly effective at clearing these plaques, the clinical results are a … Read more

Engineered Stem Cells Become Lifelong Protein Factories

by

The Dawn of ‘One-and-Done’ Immunity: Beyond Traditional Vaccines For decades, the battle against rapidly mutating viruses like the flu and HIV has been a game of catch-up. Since these pathogens evolve so quickly, our immune systems often find their previous defenses obsolete, necessitating annual boosters or leaving us vulnerable to latest strains. View this post … Read more

Study finds long COVID leaves a distinct immune signature in the blood

by

Unlocking Long COVID: New Protein Patterns Offer Hope for Diagnosis and Treatment Recent research is shedding light on the complex biological mechanisms behind Long COVID, identifying distinct protein patterns in the blood that differentiate those still struggling with symptoms months after infection from those who have recovered. A study published in Communications Medicine reveals key … Read more

Study explains why vaccines underperform in people living with obesity

by

Obesity’s Impact on Vaccine Effectiveness: A Shift Towards Tissue-Specific Immunity For years, vaccine development has largely focused on stimulating a robust antibody response. However, emerging research suggests this approach may be less effective in individuals with obesity. A recent study published in The Journal of Immunology reveals that obesity significantly impairs the quality and longevity … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]